What is LeadScope?
LeadScope operates as a premier provider of computational toxicology solutions, serving a diverse clientele that spans pharmaceutical giants, chemical manufacturers, and consumer product conglomerates. By integrating proprietary research with extensive, publicly-curated toxicity databases, the company enables organizations to navigate complex regulatory environments with precision. Their platform, which hosts data on over 200,000 chemicals and 500,000 studies, serves as a foundational tool for researchers aiming to streamline safety evaluations and ensure defendable, regulatory-accepted outcomes in product development.
How much funding has LeadScope raised?
LeadScope has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in LeadScope
PPP
Public-Private Partnership
What's next for LeadScope?
With the successful closure of this financing round, LeadScope is positioned to scale its infrastructure to meet the rising demand for automated, data-driven risk assessment tools. The company is likely to prioritize the expansion of its database capabilities and the refinement of its machine learning algorithms to further reduce the reliance on traditional, time-intensive laboratory testing. By strengthening its strategic partnerships with international regulatory agencies, LeadScope aims to set the industry standard for predictive toxicology, effectively bridging the gap between raw chemical data and actionable safety insights for global stakeholders.
See full LeadScope company page
